Researchers from theIndian Institute of Technology Roorkee (IITRoorkee)have deciphered a novel mechanism of Disulfiram in treating blood infections and pneumonia caused by the Metallo-beta-lactamase producing Acinetobacter baumannii, a nosocomialtop priority pathogen. The research team led by Prof. Ranjana Pathania discovered that the drug Disulfiram can prevent the normal functioning of Metallo-β-lactamase, an enzyme that neutralizeslast resort carbapenem antibiotics.Disulfiram thus improves …